ACURA PHARMACEUTICALS, INCACUR
| Dec 31, 2011 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 |
---|
Net loss | - | - | - | - | - | - | - | - | - | -1 |
---|
Depreciation | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
---|
Share-based Compensation, Total | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
---|
Amortization of intangible asset | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
---|
Amortization of right of use asset | - | - | - | - | - | - | - | - | - | 0 |
---|
Impairment charge on intangible asset | - | - | - | - | - | - | - | - | 1 | 0 |
---|
Sales return liability | - | - | - | - | - | 0 | 0 | - | 0 | - |
---|
Gains on forgiveness of loans under CARES Act | - | - | - | - | - | - | - | - | - | -1 |
---|
Royalty receivable | - | - | - | - | 0 | 0 | 0 | -0 | -0 | - |
---|
Collaboration revenue receivable from related party | - | - | - | - | 0 | -0 | - | 0 | 0 | -0 |
---|
License fee receivable from related party | - | - | - | - | - | - | - | - | 0 | -0 |
---|
Prepaid expenses and other current assets | 0 | 0 | -0 | -0 | -0 | 0 | -0 | -0 | 0 | 0 |
---|
Income taxes refundable | 0 | -0 | - | - | - | 0 | - | -0 | - | - |
---|
Accounts payable | 0 | -1 | -0 | -0 | -0 | -0 | 1 | -0 | -0 | 0 |
---|
Accrued expenses | -0 | 0 | 0 | -0 | 0 | 0 | -0 | -0 | 0 | -0 |
---|
Accrued interest on related party loans | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
---|
Other current liabilities | - | - | - | - | -0 | 0 | 0 | 0 | 0 | 0 |
---|
Net cash used in operating activities | 12 | -14 | - | - | - | -5 | -4 | -1 | -1 | -1 |
---|
Proceeds from distribution of RSU awards | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
---|
Statutory minimum payroll withholding taxes paid on the distribution of shares pursuant to RSU awards | 2 | 1 | 1 | - | - | - | - | - | 0 | 0 |
---|
Proceeds from Short-term Debt | - | - | - | - | - | - | - | - | 0 | 0 |
---|
Proceeds from Related Party Debt | - | - | - | - | - | - | 4 | 1 | - | 0 |
---|
Payments on finance lease | - | - | - | - | - | - | - | - | - | 0 |
---|
Net cash provided by financing activities | -1 | 12 | - | - | - | 1 | 2 | 1 | 0 | 0 |
---|
Net decrease in cash | - | - | - | - | - | - | -2 | 1 | -0 | -0 |
---|
Interest Paid, Net | - | - | - | - | - | 0 | 1 | - | - | - |
---|